Regulation of T:B cell interactions by the Inducible Costimulator molecule:: Does ICOS "induce" disease?

被引:25
|
作者
Shilling, Rebecca A.
Bandukwala, Hozefa S.
Sperling, Anne I.
机构
[1] Univ Chicago, Dept Med, Sect Pulm & Crit Care, Chicago, IL 60637 USA
[2] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA
关键词
ICOS; T cells; B cells; follicular T helper cells; autoimmunity; allergy; asthma; polymorphisms; humoral immunity;
D O I
10.1016/j.clim.2006.04.574
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Inducible Costimulator molecule (ICOS), a member of the CD28 family of costimulatory molecules, was identified in 1999 as a molecule expressed primarily on activated human T cells. Induced upon activation, ICOS appears to be an ideal target for modifying T-cell-mediated immune responses. ICOS was also found to be highly expressed on germinal center T cells, suggesting that ICOS was involved in T-B cell interactions. While ICOS has subsequently been shown to be important for both Th1 and Th2 cell activation and effector function, a central role for ICOS in the generation and maintenance of humoral immunity is emerging. In this review, we summarize the evidence that the level of ICOS expression regulates T-cell-dependent B cell responses and propose a model for the rote of ICOS in diseases characterized by dysregulated humoral immunity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 50 条
  • [1] THE INDUCIBLE COSTIMULATOR ICOS IN THE REGULATION OF T FOLLICULAR HELPER CELLS
    Weber, J. P.
    Franke, R. K.
    Fuhrmann, F.
    Van, D. Vu
    Burmeister, Y.
    Hutloff, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 129 - 129
  • [2] The inducible costimulator ICOS in the regulation of T follicular helper cells
    Franke, R. K.
    Weber, J. P.
    Fuhrmann, F.
    Van, D. Vu
    Burmeister, Y.
    Hutloff, A.
    IMMUNOLOGY, 2012, 137 : 9 - 9
  • [3] Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS)
    Simpson, Tyler R.
    Quezada, Sergio A.
    Allison, James P.
    CURRENT OPINION IN IMMUNOLOGY, 2010, 22 (03) : 326 - 332
  • [4] Expression of Inducible Costimulator (ICOS) on T Cells is Associated with HIV Disease Progression
    Prendergast, A.
    Klenerman, P.
    Goulder, P.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2008, 24 : 130 - 130
  • [5] Noncanonical NF-κB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development
    Hu, Hongbo
    Wu, Xuefeng
    Jin, Wei
    Chang, Mikyoung
    Cheng, Xuhong
    Sun, Shao-Cong
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (31) : 12827 - 12832
  • [6] Association between ICOS (inducible costimulator) polymorphisms and celiac disease susceptibility
    Padron, Diana C.
    Fernandez-Mestre, Mercedes T.
    Ogando, Violeta
    Layrisse, Zulay E.
    HUMAN IMMUNOLOGY, 2007, 68 : S57 - S57
  • [7] Regulation of mouse inducible costimulator (ICOS) expression by Fyn-NFATc2 and ERK signaling in T cells
    Tan, Andy Hee-Meng
    Wong, Siew-Cheng
    Lam, Kong-Peng
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (39) : 28666 - 28678
  • [8] Orthogonal quantification of soluble inducible T-cell costimulator (ICOS) in healthy and diseased human serum
    McKinski, Kevin
    McNulty, Dean
    Zappacosta, Francesca
    Birchler, Mary
    Szapacs, Matt
    Evans, Christopher
    JOURNAL OF PHARMACEUTICAL ANALYSIS, 2022, 12 (02) : 317 - 323
  • [9] T Cell Inducible Costimulator (ICOS) Blockade Increases the Efficacy of Imatinib in Gastrointestinal Stromal Tumor (GIST)
    Tardy, Katherine J.
    Tieniber, Andrew D.
    Kwak, Hyunjee V.
    Do, Kevin
    Wang, Aura
    Zeng, Shan
    Rossi, Ferdinando
    DeMatteo, Ronald P.
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 1) : S37 - S37
  • [10] Suppression of T cell costimulator ICOS by Δ9-tetrahydrocannabinol
    Lu, Haitian
    Kaplan, Barbara L. F.
    Ngaotepprutaram, Thitirat
    Kaminski, Norbert E.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2009, 85 (02) : 322 - 329